Pharmaceutical Contract Manufacturing (PCM) – Forecast to 2030 is estimated to be worth $100,102.8 million by 2030

IQ4I Research & Consultancy published a new report on “Pharmaceutical Contract Manufacturing (PCM) Global Market – Forecast To 2030”
This Pharmaceutical Contract Manufacturing global market report covers four segments namely Product, Application, and Geography. These segments are further segmented as follows:
Pharmaceutical Contract Manufacturing (PCM) Global Market, Based on Product:
• API Manufacturing
• Finished dosage form (FDF) Manufacturing
Pharmaceutical Contract Manufacturing (PCM) Global Market, Based on Phase
• Clinical Manufacturing
• Commercial Manufacturing
Pharmaceutical Contract Manufacturing (PCM) Global Market, Based on Application
• Oncology
• Central Nervous System
• Cardiovascular Diseases
• Infectious Diseases
• Pulmonary Diseases
• Metabolic Diseases
• Gastrointestinal Diseases
• Musculoskeletal Diseases
• Genitourinary Diseases
• Endocrine Diseases
• Other Applications

Pharmaceutical Contract Manufacturing (PCM) Global Market, Based on Geography:
• North America (U.S. and Rest of NA)
• Europe (Germany, France, Italy, and Rest of Europe)
• Asia-Pacific (China, India, Japan, and Rest of APAC)
• Rest of World (Brazil, Rest of Latin America and Middle East and Others)

Each segment of this report offers market values for its sub-segments and geographies as well. It also provides market dynamics with respect to drivers, restraints, opportunities, and the performance of major key players.